Rapport Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 05/15/2026 | 7.17 M | $224.32 M | 0.80% | 15.26% |
| TRV GP V, LLC | 05/07/2026 | 7.14 M | $223.26 M | 0.00% | 15.19% |
| ARCH VENTURE MANAGEMENT, LLC | 05/15/2026 | 3.73 M | $116.67 M | 0.00% | 7.94% |
| CAPITAL INTERNATIONAL INVESTORS | 05/13/2026 | 3.10 M | $96.94 M | -8.95% | 6.59% |
| CORMORANT ASSET MANAGEMENT, LP | 05/15/2026 | 2.96 M | $92.54 M | -2.31% | 6.30% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 2.94 M | $92.06 M | -1.99% | 6.26% |
| BLACKROCK, INC. | 05/13/2026 | 2.51 M | $78.41 M | 3.05% | 5.33% |
| SOFINNOVA INVESTMENTS, INC. | 05/15/2026 | 1.90 M | $59.59 M | 0.00% | 4.05% |
| JOHNSON & JOHNSON | 05/13/2026 | 1.78 M | $55.84 M | 0.00% | 3.80% |
| POLAR CAPITAL HOLDINGS PLC | 05/15/2026 | 1.64 M | $51.39 M | 63.47% | 3.50% |
| BAKER BROS. ADVISORS LP | 05/15/2026 | 1.55 M | $48.41 M | 0.00% | 3.29% |
| VESTAL POINT CAPITAL, LP | 05/15/2026 | 1.44 M | $44.94 M | 29.39% | 3.06% |
| 05/15/2026 | 1.33 M | $41.46 M | 100.00% | 2.82% | |
| TRV GP VI, LLC | 05/07/2026 | 969.22 K | $30.33 M | 0.00% | 2.06% |
| UBS ASSET MANAGEMENT AMERICAS INC | 05/13/2026 | 918.87 K | $28.75 M | -3.52% | 1.96% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 866.46 K | $27.11 M | -1.72% | 1.84% |
| STATE STREET CORP | 05/15/2026 | 759.55 K | $23.77 M | 6.26% | 1.62% |
| ALLIANCEBERNSTEIN L.P. | 05/15/2026 | 727.84 K | $22.08 M | -7.68% | 1.55% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 721.62 K | $22.58 M | 3.87% | 1.54% |
| PERCEPTIVE ADVISORS LLC | 05/29/2026 | 673.92 K | $21.09 M | 0.00% | 1.43% |
| SIREN, L.L.C. | 05/14/2026 | 641.47 K | $20.07 M | -9.46% | 1.37% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/15/2026 | 620.60 K | $19.42 M | 0.25% | 1.32% |
| CAPITAL WORLD INVESTORS | 05/13/2026 | 536.61 K | $16.79 M | 100.00% | 1.14% |
| SIO CAPITAL MANAGEMENT, LLC | 05/14/2026 | 366.81 K | $11.48 M | 97.99% | 0.78% |
| 05/08/2026 | 320.91 K | $10.04 M | 100.00% | 0.68% | |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 319.55 K | $10.00 M | 58.33% | 0.68% |
| KENNEDY CAPITAL MANAGEMENT LLC | 05/13/2026 | 257.43 K | $8.06 M | 44.03% | 0.55% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 05/15/2026 | 250.00 K | $7.82 M | 0.00% | 0.53% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 239.92 K | $7.51 M | -1.83% | 0.51% |
| NORTHERN TRUST CORP | 05/14/2026 | 237.99 K | $7.45 M | 7.78% | 0.51% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 224.50 K | $7.02 M | 168.90% | 0.48% |
| ENSIGN PEAK ADVISORS, INC | 05/13/2026 | 194.20 K | $6.08 M | 0.00% | 0.41% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 189.25 K | $5.92 M | 100.00% | 0.40% |
| CANDRIAM S.C.A. | 04/30/2026 | 185.93 K | $5.82 M | 100.00% | 0.40% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 175.45 K | $5.49 M | -29.06% | 0.37% |
| INVESCO LTD. | 05/12/2026 | 171.76 K | $5.37 M | -35.70% | 0.37% |
| MORGAN STANLEY | 05/15/2026 | 165.95 K | $5.19 M | -21.10% | 0.35% |
| UBS GROUP AG | 05/05/2026 | 151.76 K | $4.75 M | -32.96% | 0.32% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 150.00 K | $4.69 M | 0.00% | 0.32% |
| ARTIA GLOBAL PARTNERS LP | 05/15/2026 | 138.51 K | $4.33 M | 0.00% | 0.29% |
| FREESTONE GROVE PARTNERS LP | 05/15/2026 | 127.78 K | $4.00 M | 100.00% | 0.27% |
| PRUDENTIAL FINANCIAL INC | 05/13/2026 | 114.82 K | $3.59 M | -54.97% | 0.24% |
| SWEDBANK AB | 04/29/2026 | 113.20 K | $3.54 M | 0.00% | 0.24% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 110.83 K | $3.47 M | 220.74% | 0.24% |
| TD ASSET MANAGEMENT INC | 05/11/2026 | 99.08 K | $3.10 M | -13.99% | 0.21% |
| CITIGROUP INC | 05/11/2026 | 78.80 K | $2.47 M | 39.51% | 0.17% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 78.23 K | $2.45 M | 38.57% | 0.17% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 05/15/2026 | 75.36 K | $2.36 M | -4.20% | 0.16% |
| DAFNA CAPITAL MANAGEMENT LLC | 05/15/2026 | 75.00 K | $2.35 M | 0.00% | 0.16% |
| VOYA INVESTMENT MANAGEMENT LLC | 05/12/2026 | 72.95 K | $2.28 M | 10.28% | 0.16% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Rapport Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 167 institutional investors and hedge funds held shares of Rapport Therapeutics Inc.. The most heavily invested institutionals were:
FMR LLC: 7.17 M
TRV GP V, LLC: 7.14 M
ARCH Venture Management, LLC: 3.73 M
Capital International Investors: 3.1 M
Cormorant Asset Management, LP: 2.96 M
GOLDMAN SACHS GROUP INC: 2.94 M
111.72% of Rapport Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 52.64 M shares in the last 24 months. This purchase volume represents approximately $1.61 B in transactions.